Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sciseeit Company Limited is a biotechnology spin-off from Khon Kaen University (KKU) in Thailand, founded in 2020 by researchers from the Faculty of Science. The company specializes in translating upstream biodiversity and plant genomics research into commercial health, herbal, dietary supplement, and cosmetic products. Utilizing an integrated evidence-to-impact research pipeline, Sciseeit isolates and profiles bioactive compounds from native Thai plants, validating their efficacy and safety through molecular biology and biomedical testing. Its commercial portfolio includes the Nat series of products, such as Nat OleA for sleep support, Nat WonWi for collagen stimulation, Nat OneC for cholesterol management, and various hair and skin care formulations. The company operates in close collaboration with KKU's AC Lab to continuously develop science-backed natural health solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sciseeit.